Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0269-2019Class I

REF VV19F Reinforced Dual Lumen Cannula, 19Fr., Sterile EO, DISPOSABLE: DO NOT RE-USE CE 0473

OriGen Biomedical, Inc. / initiated 2015-03-30 / Terminated

OriGen Biomedical, Inc. began a recall of REF VV19F Reinforced Dual Lumen Cannula, 19Fr., Sterile EO, DISPOSABLE: DO NOT RE-USE CE 0473 Product Usage: The OriGen RDLC catheter is indicated for use as a... on . FDA classified it as Class I and gives the reason as "Potential for clear extension tube to separate from the hub, which could result in blood loss and may require intervention to prevent permanent impairment/damage". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0269-2019
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
OriGen Biomedical, Inc.
Product
REF VV19F Reinforced Dual Lumen Cannula, 19Fr., Sterile EO, DISPOSABLE: DO NOT RE-USE CE 0473 Product Usage: The OriGen RDLC catheter is indicated for use as a single cannula for both venous drainage and arterial re-infusion of blood in the internal jugular vein during extracorporeal life support procedures of six hours or less.
Product code
DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass
Reason for recall
Potential for clear extension tube to separate from the hub, which could result in blood loss and may require intervention to prevent permanent impairment/damage
FDA root cause
Mixed-up of materials/components
Action
On April 1, 2015 the firm sent an MEDICAL DEVICE MARKET WITHDRAWAL to customers/distributors via email to inform them the catheters may start to show signs of failure at the junction of the clear extension tube and blue hub connection that can be recognized by air entrainment or blood leakage. If the preliminary failure is identified, the catheter should be replaced immediately. Serious injuries could occur due to the failure mode. The customers are instructed to discontinue use of all products from the affected lot and to return any unused products immediately and to complete and return the acknowledgement and receipt form even if the customer does not currently have products in its inventory. The firm is conducting an investigation to determine root cause of the failure and will notify the customers when the investigation has been completed and when replacement products are available. If customers have any questions regarding the return of product or the status of the investigation, they can contact: OriGen Biomedical Attn: Bernie R Silvers 7000 Burleson Road, Building D Austin, TX 78744 Phone Number +1 512-474-7278
Quantity in commerce
134
Distribution
Worldwide Distribution - US Nationwide in the states of: AR, AZ, CA, FL, GA, IL, IN, LA, MA, MI, MO, NC, NY, OH, OR, PA, RI, TX, WA, and WI OUS: Belgium, Canada, Germany, Kingdom of Saudi Arabia, Poland, Spain Sweden, Thailand and United Kingdom
Product codes and lots
Product Code UDI Lot VV19F 00816203022097 N18394

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0269-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0269-2019Class ITerminatedVoluntary: Firm initiated